![David Reese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Reese
Vorstandsvorsitzender bei
KAI Pharmaceuticals, Inc.
Vermögen: 18 Mio $ am 31.08.2026
Profil
Der Gründer von Translational Oncology Research International, Inc. David M. Reese ist Executive Vice President-Research & Development bei Amgen, Inc. Dr. Reese hatte zuvor die Position des Director-Clinical Research bei Breast Cancer International Research Group Ltd. und des Director-Clinical Research bei Translational Research In Oncology inne. Er erhielt einen Bachelor-Abschluss vom Harvard College und einen Bachelor-Abschluss vom University of Cincinnati College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMGEN INC. 0.01% | 07.05.2026 | 42’256 ( 0.01% ) | 18 Mio $ | 31.08.2026 |
Aktive Positionen von David Reese
| Unternehmen | Position | Beginn |
|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Präsident | - |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Direktor/Vorstandsmitglied | - |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Vorstandsvorsitzender | - |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Präsident | - |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Direktor/Vorstandsmitglied | 22.04.2023 |
Ehemalige bekannte Positionen von David Reese
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.06.2026 |
Translational Oncology Research International, Inc.
 Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Gründer | 01.01.2005 |
Breast Cancer International Research Group Ltd.
 Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Cancer International Research Group (CIRG) is a not-for-profit academic research organization focused on oncology and is part of the TRIO group, which encompasses the Breast Cancer International Research Group and a clinical trial operations branch. The private company is based in Edmonton, Canada. CIRG offers clinical research services, managing studies from small dose-finding trials to large phase III registration trials. The organization supports clinical research across all phases of drug development, utilizing translational approaches based on the biology of diseases, and provides flexible services to meet various sponsor requirements. The Canadian company was founded by Alessandro Riva. | Corporate Officer/Principal | 01.01.2003 |
| CHEMOCENTRYX, INC. | Vorstandsvorsitzender | - |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von David Reese
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Commercial Services |
The University of Cincinnati College of Medicine
 The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Translational Research In Oncology
 Translational Research In Oncology Miscellaneous Commercial ServicesCommercial Services Operates as an oncology clinical research organization | Commercial Services |
Translational Oncology Research International, Inc.
Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Health Technology |
Breast Cancer International Research Group Ltd.
Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Cancer International Research Group (CIRG) is a not-for-profit academic research organization focused on oncology and is part of the TRIO group, which encompasses the Breast Cancer International Research Group and a clinical trial operations branch. The private company is based in Edmonton, Canada. CIRG offers clinical research services, managing studies from small dose-finding trials to large phase III registration trials. The organization supports clinical research across all phases of drug development, utilizing translational approaches based on the biology of diseases, and provides flexible services to meet various sponsor requirements. The Canadian company was founded by Alessandro Riva. | Commercial Services |
